These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 37470668)

  • 61. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
    Andriani F; Bertolini G; Facchinetti F; Baldoli E; Moro M; Casalini P; Caserini R; Milione M; Leone G; Pelosi G; Pastorino U; Sozzi G; Roz L
    Mol Oncol; 2016 Feb; 10(2):253-71. PubMed ID: 26514616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The roles and implications of RNA m
    Deng X; Qing Y; Horne D; Huang H; Chen J
    Nat Rev Clin Oncol; 2023 Aug; 20(8):507-526. PubMed ID: 37221357
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell plasticity in regeneration in the stomach and beyond.
    Adkins-Threats M; Mills JC
    Curr Opin Genet Dev; 2022 Aug; 75():101948. PubMed ID: 35809361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Silencing of developmental genes by H3K27me3 and DNA methylation reflects the discrepant plasticity of embryonic and extraembryonic lineages.
    Yang X; Hu B; Hou Y; Qiao Y; Wang R; Chen Y; Qian Y; Feng S; Chen J; Liu C; Peng G; Tang F; Jing N
    Cell Res; 2018 May; 28(5):593-596. PubMed ID: 29463899
    [No Abstract]   [Full Text] [Related]  

  • 66. Cellular Plasticity in Cancer.
    Yuan S; Norgard RJ; Stanger BZ
    Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
    Yang Y; Wang Y
    Front Immunol; 2021; 12():640369. PubMed ID: 33868269
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
    Tien FM; Lu HH; Lin SY; Tsai HC
    J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
    Yamada Y; Beltran H
    Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer.
    Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B
    Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epigenetic plasticity of enhancers in cancer.
    Yao J; Chen J; Li LY; Wu M
    Transcription; 2020 Feb; 11(1):26-36. PubMed ID: 31944157
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior.
    Hashimoto K; Yamada Y; Semi K; Yagi M; Tanaka A; Itakura F; Aoki H; Kunisada T; Woltjen K; Haga H; Sakai Y; Yamamoto T; Yamada Y
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):758-763. PubMed ID: 28057861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transcriptional control of cancer metastasis.
    Ell B; Kang Y
    Trends Cell Biol; 2013 Dec; 23(12):603-11. PubMed ID: 23838335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Editorial: Epigenetic, metabolic, and transcriptional regulation of immune cell plasticity and functions in cancer and non-cancer diseases.
    Dai Y; Ren D; He Y; Yi H
    Front Immunol; 2023; 14():1284124. PubMed ID: 37818355
    [No Abstract]   [Full Text] [Related]  

  • 75. Environmental control of lineage plasticity and stem cell memory.
    Gola A; Fuchs E
    Curr Opin Cell Biol; 2021 Apr; 69():88-95. PubMed ID: 33535130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis.
    Hölzel M; Tüting T
    Trends Immunol; 2016 Jun; 37(6):364-374. PubMed ID: 27151281
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer.
    Ellis L
    Pharmacogenomics; 2017 May; 18(7):597-600. PubMed ID: 28468521
    [No Abstract]   [Full Text] [Related]  

  • 78. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
    Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
    Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution.
    Imamura J; Ganguly S; Muskara A; Liao RS; Nguyen JK; Weight C; Wee CE; Gupta S; Mian OY
    Front Endocrinol (Lausanne); 2023; 14():1191311. PubMed ID: 37455903
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.
    Zhuang X; Zhang H; Hu G
    Trends Pharmacol Sci; 2019 Jun; 40(6):419-429. PubMed ID: 31078320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.